EPO Patent EP4629958A1: Surface Treated Filler and Dental Composition

The European Patent Office has published patent application EP4629958A1 concerning a surface-treated filler for dental compositions. The patent, filed by Solventum Intellectual Properties Company, details a specific filler treatment and its application in dental materials.

EPO Patent Publication: Formulation for Aromatizing a Food Product

The European Patent Office has published patent application EP4630411A1 for a formulation for aromatizing a food product, filed by Döhler GmbH. The publication date is March 18, 2026.

EPO Patent Granted for Combination Vaccines

The European Patent Office has published a patent (EP4604995A1) for combination vaccines against coronavirus, influenza, and RSV infections. The patent was granted to BioNTech SE and Pfizer Inc., with a publication date of March 18, 2026.

Evonik Operations GmbH Patent EP4619454A1 on Polyoxyalkylene Compounds

The European Patent Office has published patent application EP4619454A1 filed by Evonik Operations GmbH. The patent covers polyoxyalkylene-1,2-dimyristoyl-glycerol compounds with specific poly(ethylene oxide) side chains. This publication is part of the routine EPO Bulletin for pharmaceutical-related patents.

Process for Producing a Lactoferrin-Containing Product

The European Patent Office has published patent application EP4629833A1 detailing a process for producing a lactoferrin-containing product. The patent application was filed by FrieslandCampina Nederland B.V. and lists specific inventors and IPC classifications related to the process.

EPO Patent EP4630041A1 for Kit Treating Hematological Cancer

The European Patent Office has published patent application EP4630041A1 for a kit used in the treatment of hematological cancer. The patent is assigned to AvenCell Europe GmbH and was published on March 18, 2026.

EPO Patent Publication: Vaccine Against Klebsiella Pneumoniae

The European Patent Office (EPO) published patent application EP4630047A1 on March 18, 2026, concerning a vaccine against Klebsiella Pneumoniae. The applicant is Idorsia Pharmaceuticals Ltd. This publication marks a step in the patent process for a new pharmaceutical product.

EPO Patent EP4629967A1: Perfluorinated Micelles Medical Uses

The European Patent Office has published patent application EP4629967A1 concerning perfluorinated micelles and their medical uses. The application lists Commissariat à l'Energie Atomique et aux Energies Alternatives, Université Paris-Saclay, Centre National de la Recherche Scientifique, and Institut National de la Sante et de la Recherche Medicale (INSERM) as applicants.

EPO Patent Publication: Ligands specific for ASCT1

The European Patent Office (EPO) has published patent application EP4630804A1 concerning ligands specific for ASCT1. The publication includes details on applicants, inventors, and IPC classifications. This patent relates to potential therapeutic agents and is designated for several European states.

EPO Patent EP4630064A1: Somatostatin Receptor Antagonists

The European Patent Office has published patent application EP4630064A1 concerning alpha emitter labelled somatostatin receptor antagonists. The patent was published on March 18, 2026, with Ariceum Therapeutics GmbH listed as the applicant.